Volume Doubling Times and Outcomes in Stereotactic Ablative Radiotherapy of Early-stage Non-small Cell Lung Cancer

被引:0
|
作者
Chung, M. P. [1 ]
Trakul, N. [1 ]
Le, Q. [1 ]
Hara, W. Y. [1 ]
Dieterich, S. [1 ]
Maxim, P. G. [1 ]
Diehn, M. [1 ]
Loo, B. W. [1 ]
机构
[1] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
D O I
10.1016/j.ijrobp.2011.06.1110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S592 / S592
页数:1
相关论文
共 50 条
  • [31] Stereotactic Body Radiotherapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
    Hu, Chen
    JAMA ONCOLOGY, 2024, 10 (11) : 1576 - 1577
  • [32] Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes
    Tan, Vivian S.
    Correa, Rohann J. M.
    Nguyen, Timothy K.
    V. Louie, Alexander
    Malthaner, Richard A.
    Fortin, Dalilah
    Rodrigues, George B.
    Yaremko, Brian P.
    Laba, Joanna M.
    Kwan, Keith
    Gaede, Stewart
    Lee, Ting
    Ward, Aaron D.
    Warner, Andrew
    Inculet, Richard I.
    Palma, David A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (01): : 39 - 44
  • [33] Oncologic Outcomes of Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease
    Shin, Y. S.
    Song, S. Y.
    Lee, S.
    Choi, E. K.
    Kim, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S561 - S562
  • [34] Outcomes of Patients with Interstitial Lung Disease and Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy
    Vuong, S.
    Liu, M.
    Wallat, E.
    Bassetti, M. F.
    Baschnagel, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E75 - E75
  • [35] Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J. A.
    Slotman, Ben J.
    Paul, Marinus A.
    Smit, Egbert F.
    Senan, Suresh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 348 - 353
  • [36] Long-term outcomes of Stereotactic Ablative Radiotherapy for stage I non-small cell lung cancer
    Lee, S.
    Song, S. Y.
    Kim, S. S.
    Lee, S. W.
    Ahn, S. D.
    Yoon, S. M.
    Kim, Y. S.
    Park, J. H.
    Kim, J. H.
    Choi, E. K.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S655 - S655
  • [37] Stereotactic Ablative Radiotherapy in the Management of Synchronous Early Stage Non-Small Cell Lung Cancers
    Ayoub, Z.
    Brooks, E.
    Welsh, J.
    Chen, A.
    Gandhi, S.
    Heymach, J.
    Vaporciyan, A.
    Chang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S272 - S272
  • [38] Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer
    Jiang, Liyang
    Yu, Jinming
    Meng, Xiangjiao
    LANCET, 2024, 404 (10449): : 240 - 241
  • [39] Nivolumab After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
    Chang, J. Y.
    Lin, S. H.
    Dong, W.
    Liao, Z.
    Gandhi, S.
    Chun, S. G.
    Gay, C. M.
    Zhang, J.
    Fossella, F. V.
    Blumenschein, G. R.
    Cascone, T.
    Le, X.
    Pozadzides, J. V.
    Tsao, A.
    Mehmet, A.
    Welsh, J. W.
    Verma, V.
    Wistuba, I. I.
    Lee, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S71 - S71
  • [40] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86